Internal Medicine, Interventional Cardiology · Lafayette, LA
NPI
1922000801
Since 2005
Specialty
Internal Medicine, Interventional Cardiology
Code 207RI0011X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
315 Rue Louis Xiv Bldg B
Lafayette, LA, 70508
Phone (337) 269-9777
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.2M
14,506 services
Medicare patients, 2024
2,423
Average age 76
Drug cost, 2024
$4.5M
37,697 prescriptions
Company payments, 2025
$212
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jon D Leleux was code 99214 (office e&m - established), 3,135 times for 1,856 patients. In total Jon D Leleux billed 14,506 services in 99 codes, and Medicare paid $1.2M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-06-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 3,135 | 1,856 | $79.15 | $248K |
| 93000 Electrocardiogram | Office | 2,187 | 1,837 | $8.87 | $19K |
| J2785 Injection, regadenoson, 0.1 mg | Office | 1,290 | 322 | $5.44 | $7,022 |
| 93880 Duplex Scan - Extracranial Arteries | Office | 1,036 | 917 | $111.55 | $116K |
| 93306 Echocardiography (TTE/TEE) | Office | 723 | 679 | $118.85 | $86K |
| 99232 Hospital E&M - Subsequent | Facility | 553 | 175 | $54.63 | $30K |
| 93296 External Electrocardiographic Monitoring | Office | 437 | 176 | $12.10 | $5,288 |
| 93015 Electrocardiogram | Office | 436 | 411 | $45.10 | $20K |
| 93294 External Electrocardiographic Monitoring | Office | 434 | 174 | $17.93 | $7,780 |
| 99213 Office E&M - Established | Office | 338 | 318 | $50.16 | $17K |
| 93010 Electrocardiogram | Facility | 281 | 161 | $5.65 | $1,587 |
| A9555 Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 251 | 245 | $406.00 | $102K |
| 78492 Myocardial Perfusion Scan | Office | 244 | 244 | $1,023.41 | $250K |
| G0422 Intensive cardiac rehabilitation; with or without continuous ecg monitoring with exercise, per session | Office | 222 | 14 | $88.57 | $20K |
| G0423 Intensive cardiac rehabilitation; with or without continuous ecg monitoring; without exercise, per session | Office | 219 | 14 | $88.57 | $19K |
By year: 2022 $1.4M for 15,006 services; 2023 $1.4M for 14,492 services; 2024 $1.2M for 14,506 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jon D Leleux prescribed most often to Medicare patients was Metoprolol Succinate, with 3,026 prescriptions and refills. In total Jon D Leleux wrote 37,697 Medicare prescriptions that cost $4.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metoprolol Succinate Generic | 3,026 | 5,659 | 603 | $38K |
| Rosuvastatin Calcium Generic | 2,638 | 5,162 | 628 | $35K |
| Furosemide Generic | 2,130 | 3,651 | 501 | $7,100 |
| Amlodipine Besylate Generic | 1,989 | 3,919 | 442 | $11K |
| Atorvastatin Calcium Generic | 1,970 | 4,015 | 475 | $18K |
| Potassium Chloride Generic | 1,682 | 2,775 | 389 | $25K |
| Eliquis Apixaban | 1,661 | 2,244 | 261 | $1.3M |
| Ezetimibe Generic | 1,578 | 3,102 | 369 | $28K |
| Lisinopril Generic | 1,469 | 2,933 | 318 | $7,709 |
| Repatha Sureclick Evolocumab | 1,407 | 1,829 | 194 | $1.0M |
| Doxazosin Mesylate Generic | 1,218 | 2,368 | 258 | $15K |
| Xarelto Rivaroxaban | 1,161 | 1,754 | 194 | $959K |
| Clopidogrel Clopidogrel Bisulfate | 1,106 | 2,340 | 264 | $9,704 |
| Isosorbide Mononitrate Er Isosorbide Mononitrate | 1,018 | 1,883 | 220 | $8,909 |
| Carvedilol Generic | 837 | 1,638 | 173 | $4,443 |
Brand drugs: 5,877 claims; generic drugs: 31,820 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jon D Leleux $212 ($212 in general payments such as food, travel and fees) from 3 companies. The largest payer was Stryker Corporation with $129.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.